Clorox Company (CLX) Valuation

Based on the GoodMoat Investment Framework's valuation assessment, Clorox's current price of $104.76 is 36% above the GoodMoat Target fair value estimate of $76.93. This results in a negative margin of safety, which is classified as 'Unfavourable' under the framework's DCF bands (where a margin of safety of at least 20% is required for a favourable rating). The forward P/E of approximately 16.9x is below the sector average P/E of 22.8x for household products, suggesting the market is applying a discount. However, this discount is warranted given the company's negative revenue growth (-0.8% YoY) and significant debt burden, as evidenced by a Debt/Equity ratio of nearly 9.0. The stock is not cheap relative to its quality; the high ROE of 235% is a distortion caused by a very low equity base due to high debt, not superior profitability. The 4.7% dividend yield is attractive but must be weighed against the company's financial leverage and lack of growth. Overall, the valuation fails to provide the margin of safety a value investor typically seeks, especially when considered alongside the business's fundamental challenges. Analysis based on data as of 2024-05-15.